Zenas B. Noon
Algemeen Directeur bij Pharos Pharmaceuticals, Inc.
Profiel
Dr. Zenas B.
Noon, Jr. PhD, is Chairman at Cytologics, Inc. and Chairman & Chief Executive Officer at Pharos Pharmaceuticals, Inc.
Dr. Noon was previously employed as Independent Director by Enhance Skin Products, Inc.
He received his undergraduate degree from the University of Arizona, a graduate degree from the University of Arizona, and a doctorate degree from the University of Illinois.
Actieve functies van Zenas B. Noon
| Bedrijven | Functie | Begin |
|---|---|---|
| Pharos Pharmaceuticals, Inc. | Algemeen Directeur | 01-01-1997 |
Eerdere bekende functies van Zenas B. Noon
| Bedrijven | Functie | Einde |
|---|---|---|
| ENHANCE SKIN PRODUCTS, INC. | Directeur/Bestuurslid | 22-01-2014 |
Cytologics, Inc.
 Cytologics, Inc. Pharmaceuticals: MajorHealth Technology Cytologics, Inc. manufactures pharmaceutical products. The company was founded in 1979 and is headquartered in Rochester, NY. | Voorzitter | - |
Opleiding van Zenas B. Noon
| University of Arizona | Graduate Degree |
| University of Illinois | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Cytologics, Inc.
Cytologics, Inc. Pharmaceuticals: MajorHealth Technology Cytologics, Inc. manufactures pharmaceutical products. The company was founded in 1979 and is headquartered in Rochester, NY. | Health Technology |
Enhance Skin Products, Inc.
 Enhance Skin Products, Inc. Household/Personal CareConsumer Non-Durables Enhance Skin Products, Inc. develops and markets cosmeceuticals. It offers a skin care line under its Visible Youth trademark which includes products such as topical treatment, eye zone gel, moisturizer, cleanser and healing complex formula. The company was founded on November 14, 2006 and is headquartered in Reno, NV. | Consumer Non-Durables |
| Pharos Pharmaceuticals, Inc. |
